IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-15
DOI
10.1038/s41598-017-15607-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways
- (2016) Jin-hui Wu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- PKM2 and cancer: The function of PKM2 beyond glycolysis
- (2016) GAOCHAO DONG et al. Oncology Letters
- miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer
- (2016) XUEXIANG LIU et al. Oncology Letters
- AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth
- (2016) Young Soo Park et al. Oncotarget
- IGF-I: A Key Growth Factor that Regulates Neurogenesis and Synaptogenesis from Embryonic to Adult Stages of the Brain
- (2016) Vanesa Nieto-Estévez et al. Frontiers in Neuroscience
- A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling
- (2016) Tsung-Hua Hsieh et al. Scientific Reports
- APC selectively mediates response to chemotherapeutic agents in breast cancer
- (2015) Monica K. VanKlompenberg et al. BMC CANCER
- MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential
- (2015) Wei Wang et al. Journal of Zhejiang University-SCIENCE B
- β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells
- (2015) Jinhua Xu et al. MOLECULAR CARCINOGENESIS
- miR-520h is crucial for DAPK2 regulation and breast cancer progression
- (2015) C-M Su et al. ONCOGENE
- MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity
- (2015) J Xue et al. ONCOGENE
- Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression
- (2015) Q Xu et al. ONCOGENE
- MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer
- (2015) Xiaoping Liu et al. Oncotarget
- MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines
- (2014) Masoumeh Azizi et al. CANCER BIOLOGY & THERAPY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells
- (2014) Wenjuan Li et al. PLoS One
- Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers
- (2013) Avital Gilam et al. BREAST CANCER RESEARCH AND TREATMENT
- PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells
- (2013) William J. Israelsen et al. CELL
- MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
- (2013) Y Xiang et al. ONCOGENE
- miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines
- (2013) Chen Zhu et al. PROSTATE
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- PKM2: a new player in the β-catenin game
- (2012) Frédéric Canal et al. Future Oncology
- Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line
- (2012) Elizabeth C. Martin et al. PLoS One
- MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R
- (2012) Biyun Wang et al. PLoS One
- A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1
- (2012) Qing Xu et al. Journal of Molecular Cell Biology
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2011) F. Cardoso et al. ANNALS OF ONCOLOGY
- miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer
- (2011) T. Tsuruta et al. CANCER RESEARCH
- PKM2: A gatekeeper between growth and survival
- (2011) Isaac Harris et al. CELL RESEARCH
- Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
- (2011) Weiwei Yang et al. NATURE
- Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
- (2011) J Chen et al. ONCOGENE
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1
- (2010) Jinfeng Huang et al. HEPATOLOGY
- Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance
- (2010) Yue Chen et al. JOURNAL OF GASTROINTESTINAL SURGERY
- MicroRNA roles in beta-catenin pathway
- (2010) Kai Huang et al. Molecular Cancer
- MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes
- (2009) Chiara Braconi et al. HEPATOLOGY
- Mechano-transduction in Osteoblastic Cells Involves Strain-regulated Estrogen Receptor α-mediated Control of Insulin-like Growth Factor (IGF) I Receptor Sensitivity to Ambient IGF, Leading to Phosphatidylinositol 3-Kinase/AKT-dependent Wnt/LRP5 Receptor-independent Activation of β-Catenin Signaling
- (2009) Andrew Sunters et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started